Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in Brain Metastasis from Breast and NSCLC
NCT01913067Phase 2Withdrawn
- Sponsor
- Institut Jules Bordet
- Start
- Sep 2013
- Primary completion
- May 2016
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cabazitaxel ginsenoside liposome injection in brain metastasis (BM), sponsored by Institut Jules Bordet. Planned start Sep 2013; status: withdrawn.
02
Drugs
cabazitaxel ginsenoside liposome injection
03
Conditions
brain metastasis (BM)
Beyond the preview
Go deeper on NCT01913067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01913067.